About Us

After a successful conference in 2017, ConferenceSeries Ltd is very much delighted to invite you all to the "5th International Conference on Depression, Anxiety and Stress Management" (Depression 2018) scheduled on November 05-06, 2018 at Bangkok, Thailand. We are progressively working for the initiation of the new world, perspectives and views in the field of Psychiatry and NeurologyConferenceSeries Ltd is providing a great platform for thousands of psychiatrists and neurologists to meet, learn, share and exchange views. We are concentrating on a view that everyone should gain from the conference. So, we are organizing plenary sessions, poster exhibitions and section programs, workshops at the conference.
 
Depression 2018 is supported by related journals and their editorial board members which provide a chance of meeting them, along with experts in Psychiatry and Neurological Sciences.
 
Depression 2018 will be a great event where experts from universities, top pharmaceutical industries, research centers and from the societies and association related to Psychiatry and Neurology gather and share their insights. So, all are wholeheartedly invited to be a part of this conference.
 
2018 Highlights:
  • 150+ Participation (70% Industry: 30% Academia)
  • 5+ Keynote Speakers
  • 30+ Plenary Speakers
  • 3+ Exhibitors
  • 20+ Innovative Educational Sessions
  • B2B Meetings

Exhibition:

Why exhibit:
 
  • Make deals 
  • Entrance new items 
  • Profile your product 
  • Meet new business accomplices and providers 
  • Create key connections
 
Why you should attend:
 
  • Participate in the empowering event orchestrate, with round tables, boards, displays, speed organizing and various social event tracks. 
  • Offer experiences, bits of learning and methods in instinctive shared roundtables. 
  • Hear more perspectives in a single place – from broad medium and little associations from psychiatry, neurology, and the insightful group. 
  • Discover how intelligent specifying movements are being realized before long. 
  • Get profoundly of why enumerating and movement methodology crash and burn. Examine the troubles previously looking for strong courses of action. 
  • Get profoundly of why definition and movement approach miss the mark. Break down the challenges previously hunting down strong game plans. 
  • Discover how advances in the zone are influencing both generous and little molecule/particle drugs. 
  • Explore endeavored and attempted courses to upgrade the treatments of depression
  • Perceive how to develop the right arrangement and transport framework with a strong legitimate, clinical and business standpoint. 
  • Locate the latest headways in psychiatry and neurological sciences.